Overview

Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-801)

Status:
Completed
Trial end date:
2004-07-01
Target enrollment:
Participant gender:
Summary
This study will evaluate patients who have coronary heart disease to determine if an investigational drug will further lower cholesterol when taken in combination with an approved cholesterol lowering medication.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Ezetimibe